CPLX2

Origem: Wikipédia, a enciclopédia livre.
Ir para: navegação, pesquisa

A complexina 2 (também conhecida como CPLX2), é uma proteína que em seres humanos é codificada pelo gene CPLX2.[1]

As proteínas codificadas pela família genética complexina/sinapsina são proteínas citosólicas que actuam na exocitose de vesículas sinápticas. Estas proteínas ligam-se à sintaxina, parte do receptor SNAP. O produto proteíco deste gene liga-se ao receptor SNAP, causando a sua disrupção e assim causando a libertação de transmissor. Duas variantes de transcriptos codificando a mesma proteína foram encontradas para este gene.[1]

Referências[editar | editar código-fonte]

  1. a b Entrez Gene: CPLX2 complexin 2.

Leitura de apoio[editar | editar código-fonte]

  • Abe T. (2002). "[The mechanism of neurotransmitter release: role of synaphin/complexin in synaptic vesicle exocytosis]". Tanpakushitsu Kakusan Koso 47 (7): 794–800. PMID 12058476.
  • Christensen VL, Johnston NP. (1978). "Effect of time of day of insemination and the position of the egg in the oviduct on the fertility of turkeys.". Poult. Sci. 56 (2): 458–62. PMID 605033.
  • Morgans CW, Brandstätter JH, Kellerman J, et al.. (1996). "A SNARE complex containing syntaxin 3 is present in ribbon synapses of the retina.". J. Neurosci. 16 (21): 6713–21. PMID 8824312.
  • Harrison PJ, Eastwood SL. (1998). "Preferential involvement of excitatory neurons in medial temporal lobe in schizophrenia.". Lancet 352 (9141): 1669–73. DOI:10.1016/S0140-6736(98)03341-8. PMID 9853440.
  • Ishizuka T, Saisu H, Odani S, et al.. (1999). "Distinct regional distribution in the brain of messenger RNAs for the two isoforms of synaphin associated with the docking/fusion complex.". Neuroscience 88 (1): 295–306. DOI:10.1016/S0306-4522(98)00223-1. PMID 10051208.
  • Yamada M, Saisu H, Ishizuka T, et al.. (1999). "Immunohistochemical distribution of the two isoforms of synaphin/complexin involved in neurotransmitter release: localization at the distinct central nervous system regions and synaptic types.". Neuroscience 93 (1): 7–18. DOI:10.1016/S0306-4522(99)00104-9. PMID 10430466.
  • Pabst S, Hazzard JW, Antonin W, et al.. (2000). "Selective interaction of complexin with the neuronal SNARE complex. Determination of the binding regions.". J. Biol. Chem. 275 (26): 19808–18. DOI:10.1074/jbc.M002571200. PMID 10777504.
  • Eastwood SL, Cotter D, Harrison PJ. (2001). "Cerebellar synaptic protein expression in schizophrenia.". Neuroscience 105 (1): 219–29. DOI:10.1016/S0306-4522(01)00141-5. PMID 11483314.
  • Eastwood SL, Harrison PJ. (2001). "Synaptic pathology in the anterior cingulate cortex in schizophrenia and mood disorders. A review and a Western blot study of synaptophysin, GAP-43 and the complexins.". Brain Res. Bull. 55 (5): 569–78. DOI:10.1016/S0361-9230(01)00530-5. PMID 11576753.
  • Pabst S, Margittai M, Vainius D, et al.. (2002). "Rapid and selective binding to the synaptic SNARE complex suggests a modulatory role of complexins in neuroexocytosis.". J. Biol. Chem. 277 (10): 7838–48. DOI:10.1074/jbc.M109507200. PMID 11751907.
  • Sawada K, Young CE, Barr AM, et al.. (2002). "Altered immunoreactivity of complexin protein in prefrontal cortex in severe mental illness.". Mol. Psychiatry 7 (5): 484–92. DOI:10.1038/sj.mp.4000978. PMID 12082566.
  • Hu K, Carroll J, Rickman C, Davletov B. (2003). "Action of complexin on SNARE complex.". J. Biol. Chem. 277 (44): 41652–6. DOI:10.1074/jbc.M205044200. PMID 12200427.
  • Strausberg RL, Feingold EA, Grouse LH, et al.. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. DOI:10.1073/pnas.242603899. PMID 12477932.
  • Edwardson JM, Wang CT, Gong B, et al.. (2003). "Expression of mutant huntingtin blocks exocytosis in PC12 cells by depletion of complexin II.". J. Biol. Chem. 278 (33): 30849–53. DOI:10.1074/jbc.M304615200. PMID 12807877.
  • Ota T, Suzuki Y, Nishikawa T, et al.. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs.". Nat. Genet. 36 (1): 40–5. DOI:10.1038/ng1285. PMID 14702039.
  • Gerhard DS, Wagner L, Feingold EA, et al.. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).". Genome Res. 14 (10B): 2121–7. DOI:10.1101/gr.2596504. PMID 15489334.
  • Eastwood SL, Harrison PJ. (2005). "Decreased expression of vesicular glutamate transporter 1 and complexin II mRNAs in schizophrenia: further evidence for a synaptic pathology affecting glutamate neurons.". Schizophr. Res. 73 (2-3): 159–72. DOI:10.1016/j.schres.2004.05.010. PMID 15653259.
  • DiProspero NA, Chen EY, Charles V, et al.. (2005). "Early changes in Huntington's disease patient brains involve alterations in cytoskeletal and synaptic elements.". J. Neurocytol. 33 (5): 517–33. DOI:10.1007/s11068-004-0514-8. PMID 15906159.
Ícone de esboço Este artigo sobre Genética é um esboço. Você pode ajudar a Wikipédia expandindo-o.